When does Gammagard’s patent expire?
Gammagard (intravenous immune globulin, IgG) is an older biologic, and the exact “go-off patent” timing depends on which patent set you mean (the original biologic patents, later formulation/manufacturing patents, and any regulatory exclusivity that applies). The provided information does not include Gammagard’s specific patent numbers or expiry dates, so I can’t give a reliable date.
Can you clarify what you’re looking for?
People usually mean one of these:
- The first patent that blocks generic/“biosimilar” competition.
- The last patent preventing biosimilar approval/marketing.
- Regulatory exclusivity (not a patent) tied to approval in the U.S.
If you tell me whether you mean the U.S. or another country, and whether you want the earliest or latest patent-related date, I can narrow down what to check.
How to find the right “patent expiry” for Gammagard (practical approach)
To get the real answer, you typically look up:
- The brand’s biologics license/approval record.
- The associated patent list submitted to regulators (e.g., the U.S. FDA Orange Book for exclusivities and, for biologics, the Patent/Exclusivity listings).
- Any court decisions or settlements that affect effective launch timing.
Quick question
Do you mean Gammagard Liquid/other specific Gammagard product, and is this for the U.S.?